10-Year Cumulative Incidence and Indications for Revision Total Knee Arthroplasty Among Patients Who Have Sickle Cell Disease
The Journal of Arthroplasty · 2023
DOI: 10.1016/j.arth.2023.03.070 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2023. Verfasst von Philip M Parel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Prosthesis-Related Infections, Knee Prosthesis, Arthritis, Infectious. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Literature regarding total knee arthroplasty (TKA) outcomes in sickle cell disease (SCD) is limited. Moreover, 10-year survivorship of SCD implants is unknown. This study aimed to observe 10-year cumulative incidence and indications for revision TKA in patients who did and did not have SCD. METHODS: Patients who underwent primary TKA were identified using a large national database. The SCD patients were matched by age, sex, and a comorbidity index to a control cohort in a 1:4 ratio. The 10-year cumulative incidence rates were determined using Kaplan-Meier survival analyses. Multivariable analyses were conducted using Cox proportional hazard modeling. Chi-squared analyses were conducted to compare indications for revision between cohorts. In total, 1,010 SCD patients were identified, 100,000 patients included in the unmatched control, and 4,020 patients included in the matched control. RESULTS: Compared to the unmatched control cohort, SCD patients exhibited higher 10-year all-cause revision (HR: 1.86; P < .001) with higher proportions of revisions for periprosthetic joint infection (PJI) (P < .001), aseptic loosening (P < .001), and hematoma (P < .001). Compared to the matched control, SCD patients had higher 10-year all-cause revision (Hazard Ratio (HR): 1.39; P = .034) with a higher proportion of revisions for PJI (P = .044), aseptic loosening (P = .003), and hematoma (P = .019). CONCLUSION: Independent of other comorbidities, SCD patients are more likely to undergo revisions for PJI, aseptic loosening, and hematoma compared to patients who do not have SCD. Due to the high-risk of these complications, perioperative and postoperative surgical optimization should be enforced in SCD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
- Department of Orthopaedic Surgery, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia; Department of Orthopaedic Surgery, Johns Hopkins University School of Medicin…
- Department of Orthopaedic Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
- Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Department of Orthopaedic Surgery, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
Zitieren
APA
Parel, P. M., Kuyl, E. V., Agarwal, A. R., Cohen, J. S., Gu, A., Harris, A. B., Ranson, R. A., Thakkar, S. C., & Golladay, G. J. (2023). 10-Year Cumulative Incidence and Indications for Revision Total Knee Arthroplasty Among Patients Who Have Sickle Cell Disease. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2023.03.070
Vancouver
Parel PM, Kuyl EV, Agarwal AR, Cohen JS, Gu A, Harris AB, et al. 10-Year Cumulative Incidence and Indications for Revision Total Knee Arthroplasty Among Patients Who Have Sickle Cell Disease. The Journal of Arthroplasty. 2023. doi:10.1016/j.arth.2023.03.070
BibTeX
@article{Parel2023,
author = {Parel, Philip M and Kuyl, Emile-Victor and Agarwal, Amil R and Cohen, Jordan S and Gu, Alex and Harris, Andrew B and Ranson, Rachel A and Thakkar, Savyasachi C and Golladay, Gregory J},
title = {10-Year Cumulative Incidence and Indications for Revision Total Knee Arthroplasty Among Patients Who Have Sickle Cell Disease},
journal = {The Journal of Arthroplasty},
year = {2023},
doi = {10.1016/j.arth.2023.03.070}
}
EUVIMED